The FY2025 (Dec) proxy of Evolus names 18 peer companies for pay. Among Evolus and these peers, CEO pay was 7th highest of 8 and total shareholder return was 6th highest of 8.
7th highest of 8in Evolus and its pay peers, FY2025 (Dec) by CEO pay:
$2.9M$12.0M
6th highest of 8in Evolus and its pay peers, FY2025 (Dec) by total shareholder return:
$30$364
Pay peer group, FY2025 (Dec) proxy
| GLAUKOS | ||
| Axogen | ||
| Staar Surgical | ||
| Arcutis Biotherapeutics | ||
| Mimedx Group | ||
| Tarsus Pharmaceuticals | ||
| Establishment Labs Holdings | ||
| Agenus Inc. | Not disclosed | Not disclosed |
| Anika Therapeutics, Inc. | Not disclosed | Not disclosed |
| Bioventus Inc. | Not disclosed | Not disclosed |
| Coherus Oncology, Inc. | Not disclosed | Not disclosed |
| Harrow | Not disclosed | Not disclosed |
| InMode Ltd. | Not disclosed | Not disclosed |
| Olaplex Holdings, Inc. | Not disclosed | Not disclosed |
| Revance Therapeutics, Inc. | Not disclosed | Not disclosed |
| RxSight | Not disclosed | Not disclosed |
| The Beauty Health Company | Not disclosed | Not disclosed |
| Vericel | Not disclosed | Not disclosed |
18 companies
Changes by year
FY2025 (Dec) proxy
- AddedInMode Ltd.pay peer groupto better align the peer group with the Company’s then current size, commercial profile
- AddedOlaplex Holdings, Inc.pay peer groupto better align the peer group with the Company’s then current size, commercial profile
- AddedRxSightpay peer groupto better align the peer group with the Company’s then current size, commercial profile
- AddedStaar Surgicalpay peer groupto better align the peer group with the Company’s then current size, commercial profile
- AddedTarsus Pharmaceuticalspay peer groupto better align the peer group with the Company’s then current size, commercial profile
- AddedVericelpay peer groupto better align the peer group with the Company’s then current size, commercial profile
- RemovedAVITA Medical, Inc.pay peer groupbecause they no longer aligned with the committee’s size-based selection criteria, primarily due to revenue and market capitalization
- RemovedCara Therapeutics, Inc.pay peer groupbecause they no longer aligned with the committee’s size-based selection criteria, primarily due to revenue and market capitalization
- RemovedCutera, Inc.pay peer groupbecause they no longer aligned with the committee’s size-based selection criteria, primarily due to revenue and market capitalization
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.